Liposomes in drug delivery: a patent review (2007 – present)

Bibliography

• Arias JL. Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem 2011;11:1-17
   PubMed Web of Science ®Google Scholar
• Lammers T, Subr V, Peschke P. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer 2008;99:900-10
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009;3:16-20
   PubMed Web of Science ®Google Scholar
• Huwyler J, Drewe J, Krähenbühl S. Tumor targeting using liposomal antineoplastic drugs. Int J Nanomed 2008;3:21-9
   PubMed Web of Science ®Google Scholar
• Ulbrich W, Lamprecht A. Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J R Soc Interface 2010;7:S55-66
   PubMed Web of Science ®Google Scholar
• Yang J, Park SB, Yoon HG, et al. Preparation of poly ε-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006;324:185-90
   PubMed Web of Science ®Google Scholar
• Esmaeilia F, Dinarvand R, Ghahremani MH, et al. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles. Anticancer Drugs 2010;21:43-52
   Google Scholar
• Fischer HC, Chan WCW. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 2007;18:565-71
   PubMed Web of Science ®Google Scholar
• Dandamudi S, Campbell RB. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Biochim Biophys Acta 2007;1768:427-38
   PubMed Web of Science ®Google Scholar
• Schroeder A, Sigal A, Turjeman K, Barenholz Y. Using PEGylated nano-liposomes to target tissue invaded by a foreign body. J Drug Target 2008;16:591-5
   PubMed Web of Science ®Google Scholar
• Garg A, Tisdale AW, Haidari E, Kokkoli E. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. Int J Pharm 2009;366:201-10
   PubMed Web of Science ®Google Scholar
• Langereis S, Keupp J, van Velthoven JL, et al. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery. J Am Chem Soc 2009;131:1380-1
   PubMed Web of Science ®Google Scholar
• Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012;112:5818-78
   PubMed Web of Science ®Google Scholar
• Harashima H, Hiraiwa T, Ochi Y, Kiwada H. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. J Drug Target 1995;3:253-61
   PubMed Web of Science ®Google Scholar
• Clares B, Medina MM, Gallardo V, Ruíz MA. Multilamellar liposomes of triamcinolone acetonide: preparation, stability and characterization. J Liposome Res 2009;19:197-206
   PubMed Web of Science ®Google Scholar
• Arias JL, Clares B, Morales ME, et al. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets 2011;12:1151-65
   PubMed Web of Science ®Google Scholar
• Patel GB, Sprott GD. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit Rev Biotechnol 1999;19:317-57
   PubMed Web of Science ®Google Scholar
• Zanin MHA, Torriani ICL, Zollner RL, Santana MHA. Physical characterization of surface-modified liposomes by incorporation of gangliosides designed for immunotherapies. Colloids Surf A Physicochem Eng Asp 2004;251:175-82
   Google Scholar
• Opanasopit P, Sakai M, Nishikawa M, et al. Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers. J Control Release 2002;80:283-94
   PubMed Web of Science ®Google Scholar
• Hermes Bioscience, Inc. Liposomes useful for drug delivery. EP1746976; 2007
   Google Scholar
• The Regents of the University of California. Zhang L, Pornpattananangkul D, Huang CME. Triggered cargo release from nanoparticle stabilized liposomes. WO2011112883; 2011
   Google Scholar
• Statens Seruminstitut. Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids. EP1765289; 2007
   Google Scholar
• Bin D, Ying L, Xiaotian L, et al. Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes. Int J Pharm 2010;384:140-7
   Google Scholar
• Elmi MM, Sarbolouki MN. A simple method for preparation of immuno-magnetic liposomes. Int J Pharm 2001;215:45-50
   Google Scholar
• Alza Corp. Zhang Y, Luo B, Iyer L. Liposomal delivery vehicle for hydrophobic drugs. WO2007005754; 2007
   Google Scholar
• Pinkhassik E, Danila DC. Aminophosphonate carriers for liposome-based drug release systems. WO2009114538; 2009
   Google Scholar
• Schmidt MA, Miller JJ. Therapeutic liposomes and methods for producing and using the same. WO2011143271; 2011
   Google Scholar
• Polymun Scient Immunbio Forsch. Superloaded liposomes for drug delivery. EP1748760; 2007
   Google Scholar
• Kulkarni SB, Vargha-Butler EI. Study of liposomal drug delivery systems 2. Encapsulation efficiencies of some steroids in MLV liposomes. Colloids Surf B Biointerfaces 1995;4:77-85
   Google Scholar
• Novosom AG. Serum stable liposomes comprising amphoter II lipid mixtures. EP1764089; 2007
   Google Scholar
• Wisconsin Alumni Research Foundation. Xiong MP, Wang Y, Tu S. Liposome-encapsulated hydrogels for use in a drug delivery system. WO2012155048; 2012
   Google Scholar
• Lee S, Lee J, Choi YW. Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance. Biol Pharm Bull 2007;30:393-6
   PubMed Web of Science ®Google Scholar
• Otsuka Pharma Co. Ltd. Hirofumi T. Transpulmonary liposome for controlling drug arrival. EP2133097; 2009
   Google Scholar
• Medgenesis Therapeutix, Inc. Redelmeier T, Luz M. Liposomal composition for convection-enhanced delivery to the central nervous centre. WO2010057317; 2010
   Google Scholar
• Pacira Pharmaceuticals, Inc. Epidural administration of therapeutic compounds with sustained rate of release. EP2036542; 2009
   Google Scholar
• Nanyang Technological University, Singapore Health Services Pte. Ltd. Venkatraman S, Natarajan JV, Wong T, Boey YCF. A liposomal formulation for ocular drug delivery. WO2012021107; 2012
   Google Scholar
• Inst. Nagoya Ind. Science Res. Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye. EP2255788; 2010
   Google Scholar
• Yamakazi N, Kojima S. Sugar-modified liposome and composition for drug delivery containing the liposome. WO2007018272; 2007
   Google Scholar
• CeramOptec Industries, Inc. Farmer G, Scheglmann D, Albrecht V, Nifantiev NE. Photosensitizer formulations for topical applications. WO2007133514; 2007
   Google Scholar
• Wayne State University, Scitech Development LLC. Parchment RE, Boinpally RR, Rose SE, et al. Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery. WO2007115134; 2007
   Google Scholar
• Wang T, Deng Y, Geng Y, et al. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 2006;1758:222-31
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Mizutani Y, Nakanishi H, et al. Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma. Int J Oncol 2008;33:565-71
   PubMed Web of Science ®Google Scholar
• Sun W, Zhang N, Li A, et al. Preparation and evaluation of N3-O-toluyl-loaded liposomes. Int J Pharm 2008;353:243-50
   PubMed Web of Science ®Google Scholar
• Watanabe M, Kawano K, Toma K, et al. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J Control Release 2008;127:231-8
   PubMed Web of Science ®Google Scholar
• Türker S, Erdoğan S, Ozer YA, et al. Enhanced efficacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis. J Drug Target 2008;16:51-7
   PubMed Web of Science ®Google Scholar
• Celia C, Calvagno MG, Paolino D, et al. Improved in-vitro antitumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. J Nanosci Nanotechnol 2008;8:2102-13
   PubMed Web of Science ®Google Scholar
• Fens MH, Hill KJ, Issa J, et al. Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma. Br J Cancer 2008;99:1256-64
   PubMed Web of Science ®Google Scholar
• Astellas Pharma, Inc. Takashi S. Liposome improving intracellular drug delivery. EP1795182; 2007
   Google Scholar
• CeramOptec Industries, Inc. Albrecht V, Spaniol S, Scheglmann D. Pegylated compounds for age-related macular degeneration. WO2009067203; 2009
   Google Scholar
• Fonseca C, Moreira JN, Ciudad CJ, et al. Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells. Eur J Pharm Biopharm 2005;59:359-66
   PubMed Web of Science ®Google Scholar
• Terada T, Mizobata M, Kawakami S, et al. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J Control Release 2007;119:262-70
   PubMed Web of Science ®Google Scholar
• Willis MC, Collins BD, Zhang T, et al. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem 1998;9:573-82
   PubMed Web of Science ®Google Scholar
• Gosk S, Moos T, Gottstein C, Bendas G. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim Biophys Acta 2008;1778:854-63
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lu WL, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 2010;141:183-92
   PubMed Web of Science ®Google Scholar
• Song CK, Jung SH, Kim DD, et al. Disaccharide-modified liposomes and their in vitro intracellular uptake. Int J Pharm 2009;380:161-9
   PubMed Web of Science ®Google Scholar
• Shmeeda H, Mak L, Tzemach D, et al. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol Cancer Ther 2006;5:818-24
   PubMed Web of Science ®Google Scholar
• Wu J, Lu Y, Lee A, et al. Reversal of multidrug resistance by transferrin-conjugated liposomes coencapsulating doxorubicin and verapamil. J Pharm Pharm Sci 2007;10:350-7
   PubMed Web of Science ®Google Scholar
• The Regents of the University of California. Zasadzinski JA, Wu G, Prevo B. Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes. WO2009097480; 2009
   Google Scholar
• Dandamudi S, Campbell RB. The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007;28:4673-83
   PubMed Web of Science ®Google Scholar
• Clares B, Biedma-Ortiz RA, Sáez-Fernández E, et al. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer. Eur J Pharm Biopharm 2013; doi: 10.1016/j.ejpb.2013.01.028
   Google Scholar
• de Cuyper M, Soenen SJH, Coenegrachts K, Beek LT. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. Anal Biochem 2007;367:266-73
   PubMed Web of Science ®Google Scholar
• Gonzales M, Krishnan KM. Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 2005;293:265-70
   Web of Science ®Google Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 2001;53:285-305
   PubMed Web of Science ®Google Scholar
• Mok H, Zhang M. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin Drug Deliv 2013;10:73-87
   PubMed Web of Science ®Google Scholar
• Zheng X, Goins BA, Cameron IL, et al. Ultrasound-guided intratumoral administration of collagenase-2 improved liposome drug accumulation in solid tumor xenografts. Cancer Chemother Pharmacol 2011;67:173-82
   PubMed Web of Science ®Google Scholar
• Yang FY, Wong TT, Teng MC, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release 2012;160:652-8
   PubMed Web of Science ®Google Scholar
• The Trustees of Columbia University in the City of New York. Kohane DS, Epstein-Barash H, Borden MA. Methods, devices, and systems for on-demand ultrasound-triggered drug delivery. WO2011075557; 2011
   Google Scholar
• Speed CA. Therapeutic ultrasound in soft tissue lesions. Rheumatology 2001;40:1331-6
   PubMed Web of Science ®Google Scholar
• Schroeder A, Honen R, Turjeman K, et al. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release 2009;137:63-8
   PubMed Web of Science ®Google Scholar
• Boston Scientific Corp. Mon J. Method of treating cancer comprising introduction of heat and delivery of liposome containing an active agent or thermo-activated drug, gene or virus to tissue. WO2008039188; 2008
   Google Scholar
• Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev 2001;53:307-19
   PubMed Web of Science ®Google Scholar
• Kim MJ, Lee HJ, Lee IA, et al. Preparation of pH-sensitive long-circulating and EGFR-targeted immunoliposomes. Arch Pharm Res 2008;31:539-46
   PubMed Web of Science ®Google Scholar
• Karanth H, Murthy RS. pH-sensitive liposomes: principle and application in cancer therapy. J Pharm Pharmacol 2007;59:469-83
   PubMed Web of Science ®Google Scholar
• Northwestern University. Lee SM, Nguyen SB, O´Halloran TV. Compositions and methods for polymer-caged liposomes. WO2008154500; 2008
   Google Scholar
• Shum P, Kim JM, Thompson DH. Phototriggering of liposomal drug delivery systems. Adv Drug Deliv Rev 2001;53:273-84
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Smith BD. High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjug Chem 2000;11:805-14
   PubMed Web of Science ®Google Scholar
• The General Hospital Corp. Zhu TF, Szostak J. Uniform-sized, multi-drug carrying and photosensitive liposomes for advanced drug delivery. WO2009091531; 2009
   Google Scholar
• Davis SC, Szoka FC. Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. Bioconjug Chem 1998;9:783-92
   PubMed Web of Science ®Google Scholar
• Pak CC, Erukulla RK, Ahl PL, et al. Elastase-activated liposomal delivery to nucleated cells. Biochim Biophys Acta 1999;1419:111-26
   PubMed Web of Science ®Google Scholar
• Villar AV, Goni FM, Alonso A. Diacylglycerol effects on phosphatydilinositol-specific phospholipase C activity and vesicle fusion. FEBS Lett 2001;494:117-20
   PubMed Web of Science ®Google Scholar
• Andresen TL, Davidsen J, Begtrup M, et al. Enzymatic release of anti-tumor ether lipids by specific phospholipase A2 activation of novel liposome-forming prodrugs. J Med Chem 2004;47:1694-703
   PubMed Web of Science ®Google Scholar
• Liplasome Pharma APS ApS. Vikbjerg AF, Petersen SA, Melander F, et al. Liposomes for drug delivery and methods for preparation thereof. WO2009141450; 2009
   Google Scholar
• Academisch Medisch Centrum. Heger M. Drug delivery system for use in the treatment of vascular and vessel-related pathologies. WO2010084199; 2010
   Google Scholar
• Pakunlu RI, Wang Y, Saad M, et al. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release 2006;114:153-62
   PubMed Web of Science ®Google Scholar
• Elbayoumi TA, Torchilin VP. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur J Pharm Sci 2007;32:159-68
   PubMed Web of Science ®Google Scholar
• To BBB Holding B.V. Conjugates for targeted drug delivery across the blood-brain barrier. EP2308514; 2011
   Google Scholar
• Universitá degli Studi Magna Graecia di Catanzaro. Fresta M, Russo D, Paolino D, Cosco D. TSH-conjugated nanocarrier for the treatment of thyroid cancer. WO2012073125; 2012
   Google Scholar
• Japan Science & Tech Agency. Liposome allowing the discharge of substance entrapped therein from endosome. EP1832280; 2007
   Google Scholar
• Lammers T, Kiessling F, Hennink WE, et al. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm 2010;7:1899-912
   PubMed Web of Science ®Google Scholar
• Fang C, Zhang M. Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release 2010;146:2-5
   PubMed Web of Science ®Google Scholar
• Kenny GD, Kamaly N, Kalber TL, et al. Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo. J Control Release 2010;149:111-16
   PubMed Web of Science ®Google Scholar
• Kaimal V, Chu Z, Mahller YY, et al. Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging. Mol Imaging Biol 2011;13:886-97
   PubMed Web of Science ®Google Scholar
• Arias JL. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin Drug Deliv 2011;8:1589-608
   PubMed Web of Science ®Google Scholar
• Vaidya A, Sun Y, Feng Y, et al. Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate. Pharm Res 2008;25:2002-11
   PubMed Web of Science ®Google Scholar
• Comes Franchini M, Baldi G, Bonacchi D, et al. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. Small 2010;6:366-70
   PubMed Web of Science ®Google Scholar
• von Maltzahn G, Park JH, Agrawal A, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009;69:3892-900
   PubMed Web of Science ®Google Scholar
• Al-Jamal WT, Al-Jamal KT, Tian B, et al. Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. Mol Pharm 2009;6:520-30
   PubMed Web of Science ®Google Scholar
• Kyungpook National University Industry-Academic Cooperation Foundation, Industrial Technology Research Institute. Kim IS, Lee BH, Lu MJM, et al. Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof. WO2011081443; 2011
   Google Scholar
• Luna Innovations, Inc. Zhou Z, Lenk RP, Kepley CL. Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque. WO2012135550; 2012
   Google Scholar
• Kunzmann A, Andersson B, Thumherr T, et al. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011;1810:361-73
   PubMed Web of Science ®Google Scholar
• Grainger DW. Nanotoxicity assessment: all small talk? Adv Drug Deliv Rev 2009;61:419-21
   PubMed Web of Science ®Google Scholar
• Cattaneo AG, Gornati R, Sabbioni E, et al. Nanotechnology and human health: risks and benefits. J Appl Toxicol 2010;30:730-44
   PubMed Web of Science ®Google Scholar
• Faunce TA. Toxicological and public good considerations for the regulation of nanomaterial-containing medical products. Expert Opin Drug Saf 2008;7:103-6
   PubMed Web of Science ®Google Scholar
• Wang B, Wang Z, Feng W, et al. New methods for nanotoxicology: synchrotron radiation-based techniques. Anal Bioanal Chem 2010;398:667-76
   PubMed Web of Science ®Google Scholar